Csecsei Peter, Pusch Gabriella, Ezer Erzsebet, Berki Timea, Szapary Laszlo, Illes Zsolt, Molnar Tihamer
Department of Neurology, University of Pecs, Pecs, Hungary.
Department of Anesthesiology and Intensive Care, University of Pecs, Pecs, Hungary.
J Stroke Cerebrovasc Dis. 2018 Apr;27(4):951-956. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.040. Epub 2017 Dec 14.
In patients with acute ischemic stroke (AIS) without cardiovascular complications, we investigated the association of serum concentration of cardiac troponin (high-sensitivity cardiac troponin T [hs-cTnT]) with thrombo-inflammatory markers.
Thirty-five patients with first-ever AIS were prospectively examined. Serum hs-cTnT was measured 6 and 24 hours after stroke, whereas S100B, high-sensitivity C-reactive protein (hsCRP), soluble CD40 ligand, tissue plasminogen activator (tPA), monocyte chemoattractant protein-1 (MCP-1), and P-selectin were measured 6 and 72 hours after stroke. Severity of stroke was assessed by the National Institutes of Health Stroke Scale (NIHSS) on admission, 24 hours later, and at discharge.
Concentration of MCP-1 at 6 hours was higher in the serum of patients with worsened NIHSS by 24 hours (P = .009). Concentration of hs-cTnT at both 6 and 24 hours was higher, if NIHSS worsened by discharge (P = .026 and P = .001). A cutoff value for hs-cTnT measured at T24 greater than or equal to 9.4 predicted worsened NIHSS on discharge with a sensitivity of 81% and a specificity of 74% (area: .808, P = .002). Concentration of hs-cTnT at both 6 and 24 hours was also higher in nonsurvivors compared with survivors (P = .03, respectively), and correlated with (1) tPA levels at 6 hours (P = .001 and P = .002, respectively); (2) MCP-1 concentration at 6 hours (P = .01 and P = .015, respectively); and increased hsCRP levels at 72 hours (P = .01, respectively). Concentration of hs-cTnT at 24 hours was an independent predictor of worsened NIHSS at discharge (odds ratio: 1.58, 95% confidence interval: 1.063-2.370, P = .024).
Elevated concentration of hs-cTnT measured 24 hours after AIS is an independent predictor of progressing neurologic deficit in patients without apparent myocardial damage, and also correlates with acute elevation of tPA and MCP-1.
在无心血管并发症的急性缺血性卒中(AIS)患者中,我们研究了血清心肌肌钙蛋白浓度(高敏心肌肌钙蛋白T [hs-cTnT])与血栓炎症标志物之间的相关性。
对35例首次发生AIS的患者进行前瞻性检查。在卒中后6小时和24小时测量血清hs-cTnT,而在卒中后6小时和72小时测量S100B、高敏C反应蛋白(hsCRP)、可溶性CD40配体、组织型纤溶酶原激活剂(tPA)、单核细胞趋化蛋白-1(MCP-1)和P-选择素。入院时、24小时后及出院时采用美国国立卫生研究院卒中量表(NIHSS)评估卒中严重程度。
24小时内NIHSS恶化的患者血清中6小时时MCP-1浓度较高(P = 0.009)。如果出院时NIHSS恶化,则6小时和24小时时hs-cTnT浓度均较高(P = 0.026和P = 0.001)。在T24测量的hs-cTnT临界值大于或等于9.4可预测出院时NIHSS恶化,敏感性为81%,特异性为74%(面积:0.808,P = 0.002)。与幸存者相比,非幸存者6小时和24小时时hs-cTnT浓度也较高(分别为P = 0.03),且与(1)6小时时tPA水平相关(分别为P = 0.001和P = 0.002);(2)6小时时MCP-1浓度相关(分别为P = 0.01和P = 0.015);以及72小时时hsCRP水平升高相关(分别为P = 0.01)。24小时时hs-cTnT浓度是出院时NIHSS恶化的独立预测因子(比值比:1.58,95%置信区间:1.063 - 2.370,P = 0.024)。
AIS后24小时测量的hs-cTnT浓度升高是无明显心肌损伤患者神经功能缺损进展的独立预测因子,并且还与tPA和MCP-1的急性升高相关。